Abbott Laboratories (XSWX:ABT) Gross Profit : CHF19,734 Mil (TTM As of Dec. 2023)

View and export this data going back to 1995. Start your Free Trial

What is Abbott Laboratories Gross Profit?

Abbott Laboratories's gross profit for the three months ended in Dec. 2023 was CHF4,916 Mil. Abbott Laboratories's gross profit for the trailing twelve months (TTM) ended in Dec. 2023 was CHF19,734 Mil.

Gross Margin % is calculated as gross profit divided by its revenue. Abbott Laboratories's gross profit for the three months ended in Dec. 2023 was CHF4,916 Mil. Abbott Laboratories's Revenue for the three months ended in Dec. 2023 was CHF8,856 Mil. Therefore, Abbott Laboratories's Gross Margin % for the quarter that ended in Dec. 2023 was 55.51%.

Abbott Laboratories had a gross margin of 55.51% for the quarter that ended in Dec. 2023 => Durable competitive advantage

During the past 13 years, the highest Gross Margin % of Abbott Laboratories was 58.53%. The lowest was 54.47%. And the median was 56.52%.

Warning Sign:

Abbott Laboratories gross margin has been in long-term decline. The average rate of decline per year is -1.2%.

Abbott Laboratories Gross Profit Historical Data

The historical data trend for Abbott Laboratories's Gross Profit can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Abbott Laboratories Gross Profit Chart

Abbott Laboratories Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Gross Profit

Get a 7-Day Free Trial

18,348.09

17,417.08

22,599.50

22,834.45

19,141.48

Abbott Laboratories Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Gross Profit	Get a 7-Day Free Trial															5,012.51	4,947.70	4,981.99	4,916.39	4,888.19

Competitive Comparison of Abbott Laboratories's Gross Profit

For the Medical Devices subindustry, Abbott Laboratories's Gross Profit, along with its competitors' market caps and Gross Profit data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Abbott Laboratories's Gross Profit Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Abbott Laboratories's Gross Profit distribution charts can be found below:

* The bar in red indicates where Abbott Laboratories's Gross Profit falls into.

Abbott Laboratories Gross Profit Calculation

Gross Profit is the different between the sale prices and the cost of buying or producing the goods.

Abbott Laboratories's Gross Profit for the fiscal year that ended in Dec. 2023 is calculated as

Gross Profit (A: Dec. 2023 )	=	Revenue	-	Cost of Goods Sold
	=	34686.263	-	15544.78
	=	19,141

Abbott Laboratories's Gross Profit for the quarter that ended in Dec. 2023 is calculated as

Gross Profit (Q: Dec. 2023 )	=	Revenue	-	Cost of Goods Sold
	=	8856.417	-	3940.029
	=	4,916

Gross Profit for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was CHF19,734 Mil.

Gross Profit is the numerator in the calculation of Gross Margin.

Abbott Laboratories's Gross Margin % for the quarter that ended in Dec. 2023 is calculated as

Gross Margin % (Q: Dec. 2023 )	=	Gross Profit (Q: Dec. 2023 )	/	Revenue (Q: Dec. 2023 )
	=	(Revenue - Cost of Goods Sold)	/	Revenue
	=	4,916	/	8856.417
	=	55.51 %

A positive Gross Profit is only the first step for a company to make a net profit. The gross profit needs to be big enough to also cover related labor, equipment, rental, marketing/advertising, research and development and a lot of other costs in selling the products.

Abbott Laboratories (XSWX:ABT) Gross Profit Explanation

Warren Buffett believes that firms with excellent long term economics tend to have consistently higher margins.

Durable competitive advantage creates a high Gross Margin % because of the freedom to price in excess of cost. Companies can be categorized by their Gross Margin %

1. Greater than 40% = Durable competitive advantage
2. Less than 40% = Competition eroding margins
3. Less than 20% = no sustainable competitive advantage
Consistency of Gross Margin is key

Abbott Laboratories had a gross margin of 55.51% for the quarter that ended in Dec. 2023 => Durable competitive advantage

Abbott Laboratories Gross Profit Related Terms

Thank you for viewing the detailed overview of Abbott Laboratories's Gross Profit provided by GuruFocus.com. Please click on the following links to see related term pages.

Abbott Laboratories (XSWX:ABT) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Abbott Laboratories (XSWX:ABT) » Definitions » Gross Profit

Comparable Companies

Traded in Other Exchanges

ABT:USA ABT:Mexico 0Q15:UK ABL:Germany ABT:Chile ABTT34:Brazil ABT:Austria ABT:Argentina

Address

100 Abbott Park Road, Abbott Park, IL, USA, 60064-6400

Website

https://www.abbottinvestor.com

Abbott manufactures and markets cardiovascular and diabetes devices, adult and pediatric nutritional products, diagnostic equipment and testing kits, and branded generic drugs. Products include pacemakers, implantable cardioverter defibrillators, neuromodulation devices, coronary stents, catheters, infant formula, nutritional liquids for adults, continuous glucose monitors, and immunoassays and point-of-care diagnostic equipment. Abbott derives approximately 60% of sales outside the United States.